-
2021“…Organ doses for the uterus and prostate were calculated using National Cancer Institute CT (NCICT) software. Based on the risk models proposed by the BEIR VII report, the calculated organ doses were used to estimate the LAR of prostate and uterus cancer incidence and mortality due to radiation exposure from AP CT procedures. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2022por Rutenberg, Michael S., Hoppe, Bradford S., Starr, Jason S., Awad, Ziad, Thomas, Mathew, Morris, Christopher G., Johnson, Perry, Henderson, Randal H., Jones, Jeremy C., Gharia, Bharatsinh, Bowers, Steven, Wolfsen, Herbert C., Krishnan, Sunil, Ko, Stephen J., Babiker, Hani M., Nichols, Romaine C.“…Patients received proton therapy to a median dose of 50.4-GyRBE (range, 50.4–64.8) in 1.8-Gy fractions.Acute and late toxicities were graded per the Common Terminology Criteria for Adverse Events, version 4.0 (US National Cancer Institute, Bethesda, Maryland). In addition, disease control, patterns of failure, and survival outcomes were collected. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2023por Mukherjee, Amrita, Wiener, Howard W., Griffin, Russell L., Lenneman, Carrie, Chatterjee, Arka, Nabell, Lisle M., Lewis, Cora E., Shrestha, Sadeep“…METHODS: A clinical cohort of 1,829 HNSCC patients diagnosed between 2012 and 2018, at a National Cancer Institute (NCI)-designated cancer center was included. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2024por Yabroff, K Robin, Mariotto, Angela, Tangka, Florence, Zhao, Jingxuan, Islami, Farhad, Sung, Hyuna, Sherman, Recinda L, Henley, S Jane, Jemal, Ahmedin, Ward, Elizabeth M“…BACKGROUND: The American Cancer Society, National Cancer Institute, Centers for Disease Control and Prevention, and North American Association of Central Cancer Registries provide annual information about cancer occurrence and trends in the United States. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2025“…METHOD: This retrospective analysis was conducted from the National Cancer Institute's Surveillance Epidemiology and End Results, Clinicopathological data of patients with EC who received nCT from 2004 to 2015. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2026“…RESULTS: In-silico mining on National Cancer Institute (NCI) database identified 55 promising and structurally diverse inhibitors. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2027por Thierheimer, Marisa, Cioffi, Gino, Waite, Kristin A., Kruchko, Carol, Ostrom, Quinn T., Barnholtz-Sloan, Jill S.“…Additionally, histopathology-specific incidence-based mortality rates were calculated using the National Cancer Institute’s Surveillance, Epidemiology, and End-Results (SEER) 18 data from 2004 to 2018. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2028por Flexner, Nadia, Ng, Alena P., Ahmed, Mavra, Khandpur, Neha, Acton, Rachel B., Lee, Jennifer J., L’Abbe, Mary R.“…METHODS: Baseline and counterfactual usual intakes of sodium, total sugars, saturated fats, and calories were estimated among Canadian adults (n = 11,992) using both available days of 24 h recalls from the 2015 Canadian Community Health Survey-Nutrition. The National Cancer Institute method was used to estimate usual intakes, and adjusted for age, sex, misreporting status, weekend/weekday, and sequence of recall. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2029por Chovanec, Michal, Kalavska, Katarina, Obertova, Jana, Palacka, Patrik, Rejlekova, Katarina, Sycova-Mila, Zuzana, Orszaghova, Zuzana, Lesko, Peter, De Angelis, Valentina, Vasilkova, Lucia, Svetlovska, Daniela, Mladosievicova, Beata, Mardiak, Jozef, Pastorek, Michal, Vlkova, Barbora, Celec, Peter, Mego, Michal“…METHODS: GCT survivors (N = 142) from National Cancer Institute of Slovakia completed the Functional Assessment of Cancer Therapy Cognitive Function questionnaires during their annual follow-up visit at 9-year median (range 4-32). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2030por Schranz, Markus, Told, Reinhard, Hacker, Valentin, Reiter, Gregor S., Reumueller, Adrian, Vogl, Wolf‐Dieter, Bogunovic, Hrvoje, Sacu, Stefan, Schmidt‐Erfurth, Ursula, Roberts, Philipp K.“…Angio Tool, a National Cancer Institute algorithm, was used to skeletonize MNV properties and quantify lesion size (LS), vessel area (VA), vessel density (VD), total number of endpoints (TNE), total number of junctions (TNJ), junction density (JD), total vessel length (TVL), average vessel length (AVL) and mean‐e‐lacunarity (MEL). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2031“…OBJECTIVE: Following the outbreak of COVID-19, access to in-person oncology acupuncture service was temporarily disrupted at Dana-Farber Cancer Institute, a National Cancer Institute (NCI)-designated cancer center. During this period, a virtual acupuncturist-guided session of patient self-acupressure was implemented to provide continuity of supportive care for cancer patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2032por Chang, Yu-Jen, Le, Uyen Nguyen Phuong, Liu, Jia-Jun, Li, Sin-Rong, Chao, Shao-Ting, Lai, Hsueh-Chou, Lin, Yu-Feng, Hsu, Kai-Cheng, Lu, Chih-Hao, Lin, Cheng-Wen“…This study used an in-silico prediction approach to investigate the complex structure of SARS-CoV-2 M(pro) in compounds from the United States National Cancer Institute (NCI) database, then validate potential inhibitory compounds against the SARS-CoV-2 M(pro) in cis- and trans-cleavage proteolytic assays. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2033por Afiaz, Awan, Ivanov, Andrey A., Chamberlin, John, Hanauer, David, Savonen, Candace L., Goldman, Mary J., Morgan, Martin, Reich, Michael, Getka, Alexander, Holmes, Aaron, Pati, Sarthak, Knight, Dan, Boutros, Paul C., Bakas, Spyridon, Caporaso, J. Gregory, Del Fiol, Guilherme, Hochheiser, Harry, Haas, Brian, Schloss, Patrick D., Eddy, James A., Albrecht, Jake, Fedorov, Andrey, Waldron, Levi, Hoffman, Ava M., Bradshaw, Richard L., Leek, Jeffrey T., Wright, Carrie“…To gain a deeper understanding of the issues hindering software evaluations, as well as to determine what appears to be helpful, we performed a survey of participants involved with scientific software projects for the Informatics Technology for Cancer Research (ITCR) program funded by the National Cancer Institute (NCI). We also investigated software among this scientific community and others to assess how often infrastructure that supports such evaluations is implemented and how this impacts rates of papers describing usage of the software. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2034por Kreuter, Matthew W., Garg, Rachel, Fu, Qiang, Caburnay, Charlene, Thompson, Tess, Roberts, Christina, Sandheinrich, Dominique, Javed, Irum, Wolff, Jennifer M., Butler, Taylor, Grimes, Lauren M., Carpenter, Kelly M., Pokojski, Robin, Engelbrecht, Kristen, Howard, Valerie, McQueen, Amy“…FUNDING: 10.13039/100000054National Cancer Institute: R01CA201429.…”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2035por Yin, Jun, Yin, Wenya, Zheng, Linlin, Li, Yimin, Luo, Cheng, Zhang, Shuo, Duan, Lei, Zhou, Hang, Cheng, Kai, Lang, Jinyi, Xu, Ke“…Also, adverse events were evaluated using the National Cancer Institute’s Common Terminology Criteria for Adverse Events (CTCAE version 5.0). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2036por Christiansen, Mille Guldager, Pappot, Helle, Jensen, Pernille Tine, Mirza, Mansoor Raza, Jarden, Mary, Piil, Karin“…The objective of this study was to identify items in the National Cancer Institute’s measurement system Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) appropriate for use in a PRO tool for a population of women with endometrial or ovarian cancer undergoing treatment with taxanes (paclitaxel or docetaxel) in combination with carboplatin. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2037“…DESIGN, SETTING, AND PARTICIPANTS: This qualitative study with 43 participants was conducted at a National Cancer Institute–designated comprehensive cancer center from 2018 to 2022. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2038por Walker, Dale M., Lazarova, Tsvetelina I., Riesinger, Steven W., Poirier, Miriam C., Messier, Terri, Cunniff, Brian, Walker, Vernon E.“…The CyQUANT(®)-NF proliferation assay was used to assess cell viability after 48-h drug treatments, with the National Cancer Institute COMPARE methodology employed to characterize dose-response metrics. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2039por Agarwal, Mohit, Afzal, Obaid, Salahuddin, Altamimi, Abdulmalik Saleh Alfawaz, Alamri, Mubarak A., Alossaimi, Manal A., Sharma, Vandana, Ahsan, Mohamed Jawed“…All of the compounds were synthesized and characterized using spectral data, followed by their anticancer activity tested in a single-dose assay at 10 μM as reported by the National Cancer Institute (NCI US) Protocol against nearly 59 cancer cell lines obtained from nine panels, including non-small-cell lung, ovarian, breast, central nervous system (CNS), colon, leukemia, prostate, and cancer melanoma. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2040por Musa, Jonah, Kocherginsky, Masha, Magaji, Francis A., Maryam, Ali J., Asufi, Joyce, Nenrot, Danjuma, Burdett, Kristen, Katam, Neelima, Christian, Elizabeth N., Palanisamy, Nisha, Odukoya, Olukemi, Silas, Olugbenga A., Abdulkareem, Fatimah, Akpa, Philip, Badmos, Kabir, Imade, Godwin E., Akanmu, Alani S., Gursel, Demirkan B., Zheng, Yinan, Joyce, Brian T., Achenbach, Chad J., Sagay, Atiene S., Anorlu, Rose, Wei, Jian-Jun, Ogunsola, Folasade, Murphy, Robert L., Hou, Lifang, Simon, Melissa A.“…We enrolled women with histologically confirmed ICC with known HIV status, and FIGO staging as part of the United States of America’s National Institutes of Health/National Cancer Institute funded project titled ‘Epigenomic Biomarkers of HIV-Associated Cancers in Nigeria’. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto